[Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from

Clara Inés Agudelo1, Jaime Moreno, Olga Marina Sanabria

  • 1Grupo de Microbiologia, Instituto Nacional de Salud, Bogotá D.C., Colombia.

Abstract

Insights

Streptococcus pneumoniae surveillance from 1994-2004 revealed key serotypes and antimicrobial resistance patterns. This data is crucial for developing effective pneumococcal disease prevention strategies.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Epidemiology

Context:

  • Streptococcus pneumoniae is a leading cause of global childhood and adult morbidity and mortality.
  • Laboratory surveillance data from 1994 to 2004 provides a decade-long perspective on invasive pneumococcal isolates.

Purpose:

  • To analyze epidemiological data, serotyping, antimicrobial susceptibility, and molecular typing of invasive Streptococcus pneumoniae isolates.
  • To identify prevalent serotypes and antimicrobial resistance trends in pneumococcal infections.

Summary:

  • Analysis of 2,022 invasive isolates from 1994-2004 revealed dominant serotypes (14, 6B, 23F, 1, 5, 6A, 19F, 18C, 9V) across age groups.
  • Significant antimicrobial resistance was observed, with diminished susceptibility to penicillin (29.8%), trimethoprim-sulphamethoxazole (44.3%), and tetracycline (32.4%).
  • Molecular typing identified specific clones associated with resistance, including Spain23F-1, Spain6B-2, Spain9V-3, Colombia23F-26, and Colombia5-19.

Impact:

  • Provides essential data for designing and implementing targeted prevention strategies against pneumococcal disease.
  • Highlights the importance of ongoing surveillance to monitor serotype distribution and antimicrobial resistance.
  • Informs vaccine development and public health policies to reduce the burden of Streptococcus pneumoniae infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...